{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-030966","form_type":"8-K","ticker":"PURE","cik":"0001006028","company_name":"PURE BIOSCIENCE, INC.","filed_at":"2024-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.853013+00:00","generated_at":"2026-05-31T10:18:00.475127+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Pure Bioscience increases authorized common shares from 150M to 200M","bullets":["Shareholders approved the amendment at the Feb 21, 2024 annual meeting.","Certificate of Amendment filed with Delaware on Aug 5, 2024, effective immediately.","Authorized common stock increased by 50 million shares (33% increase)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-030966","json":"https://secwatch.observer/filing/0001493152-24-030966.json","markdown":"https://secwatch.observer/filing/0001493152-24-030966.md","text":"https://secwatch.observer/filing/0001493152-24-030966.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006028/000149315224030966/0001493152-24-030966-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006028/000149315224030966/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:18:00.475127+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}